22BRO873 : Adaptive, individualized dosing of 5-fluorouracil-based chemotherapy to improve treatment efficacy while minimizing severe toxicity: Development and evaluation of the FOX regimen
Principal Investigator
Study Number
STUDY02001873
Summary
This study is for patients with gastrointestinal (also called GI) cancer who will be treated with chemotherapy medications fluorouracil (also called 5-FU) and oxaliplatin. Researchers hope to lower the chance of the cancer growing or spreading by changing how doses of the usual chemotherapy medications are adjusted. Patients will be in the study for about 6 months with treatments every 2 weeks. It is expected about 36 people will take part in this study.
Phase
Pilot/Feasibility
Contact
Available at the following location(s)
- Lebanon
- St. Johnsbury, VT
View more details at ClinicalTrials.gov
Do you need help with some of the labels on this page?
Read our glossary of terms